Hematogenous metastasis and tumor dormancy as concepts or dogma? The continuum of vessel co-option and angiotropic extravascular migratory metastasis as an alternative
It has been accepted for many years that tumor cells spread via the circulation to distant sites. The latency period between treatment and tumor recurrence has been attributed to dormant cells in distant organs that emerge and grow as metastatic tumors. These processes are accepted with an incomplet...
Main Authors: | Claire Lugassy, Hynda K. Kleinman, Nathalie Cassoux, Raymond Barnhill |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.996411/full |
Similar Items
-
The Metastatic Capacity of Melanoma Reveals Alternative Pathways of Cancer Dissemination
by: Michela Corsini, et al.
Published: (2021-10-01) -
Whole Transcriptome Analysis of Breast Cancer Tumors during Neoadjuvant Chemotherapy: Association with Hematogenous Metastasis
by: Marina K. Ibragimova, et al.
Published: (2022-11-01) -
A narrative review of circulating tumor cells clusters: A key morphology of cancer cells in circulation promote hematogenous metastasis
by: Qiong Chen, et al.
Published: (2022-08-01) -
Tumor cell-induced platelet aggregation accelerates hematogenous metastasis of malignant melanoma by triggering macrophage recruitment
by: Yuyi Chen, et al.
Published: (2023-10-01) -
¿Electrodo extravascular o adherencias endovasculares?
by: Carolina Berenice Torres Terreros, et al.
Published: (2023-07-01)